Tech News

Modern CEO answers RFK JR. Crusle of CovIL-19 GOVERNMENT

In the rope Health’s conference on Tuesday, the Chief Executive Stéphane Stéphane

Moderina is one of the injections of Mrna-Based Covid-19 vaccine, and in the past month the company has obtained permission from food management and drugs to find the revised version of the revised. But as part of that compliment, FDA set new limits to who could get a vaccine. Earlier, vaccinating terms were recommended for anyone for six months or more. Now, the FDA says that it should be given only to people at high risk of sensitive diseases, even if 65 and older or have health problems.

BanCel said: “I think things include things.” You may have a person in your family – a parent, child, in the case of a pharmacy. Now, several provinces require medications for drug change.

Kennedy has been in a casket of medicine since he entered the role of the HHS secretary in February; Earlier in this week, Kenate Finance Finance anointed him for his offictions at the office so far.

In May, Kennedy was terminated by $ 590 million and Moderna for the development of a bird’s flu vaccine. The contract was awarded during the last days of the Beni Manu January, just before President Donald Trump’s started. Bird flu spreads in wild birds and make them out of chickens and cows of US milk cows since March 2024

That month, Kennedy announced that the HHS would not recommend vaccines for Mrna Covid-19 for healthy children and pregnant women. In June, the FDA said it would require new labels in MRNA safety goals to include Myocarditis risks and pericarditis, unusual side effects that follow gun management.

In August, as part of a designated “HHS vaccine with 22 thousand investment issues. of vaccination.

Despite the administration of the administration against Mrna, Bancel said “He is encouraged by the company” that has had FDA. In addition to renewing the Covid Rifread, though there are limits, the Moderna also received extended approval for this year with its respiratory, or RSV, vaccine, including the old risk of disease. The vaccine was initially approved in May 2024 to adults aged 60 and older.

“I think many people back in January, including my team, were so worried that we could not find those rights,” said Bancel.

Mrna’s cracking is MNNA research until now has not been expanded in cancer, and the Moderna develops a lot of cancer treatment, including the personalized cancerous policies. The company has 45-related programs in the pipe and said it expects 10 FDA approval over the next three years. “We are using the same technology to continue the infectious disease,” said Bancel.

He also expresses suspicion of experiences and was not examined. “I don’t think there has been a study vaccine learned to work well and safety in the history of vaccination,” he said. “Substance effective in vaccination and security, there are millions of people in the real world.”

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button